Recent Advances in Therapeutic Application of DNA Damage Response Inhibitors against Cancer

Area of Science:

• Molecular Biology
• Genetics
• Oncology

Background:

• DNA integrity is crucial for cellular function and is constantly threatened by internal and external factors.
• The DNA Damage Response (DDR) is a complex network of signaling pathways involving sensors, mediators, and repair proteins that maintain genomic stability.
• Defects in DDR contribute to genomic instability and are a hallmark of cancer development.

Purpose of the Study:

• To review the key components of DDR pathways.
• To elucidate the role of DDR in carcinogenesis.
• To focus on the development of DDR protein inhibitors for targeted cancer therapy.

Main Methods:

• Literature review of major DDR pathways.
• Analysis of DDR protein functions in DNA damage response and repair.
• Examination of the significance of DDR in cancer development.
• Overview of inhibitors targeting key DDR proteins.

Main Results:

• DDR pathways are essential for detecting and repairing DNA damage.
• Dysfunctional DDR is implicated in the accumulation of genetic mutations and cancer.
• Cancer cells exhibit dependencies on specific DDR pathways, making them vulnerable to DDR inhibitors.
• Structural understanding of DDR proteins has enabled the development of targeted inhibitors.

Conclusions:

• Targeted inhibition of DDR pathways represents a promising strategy for cancer treatment.
• Understanding DDR mechanisms is critical for developing effective cancer therapies.
• DDR inhibitors exploit cancer cell-specific vulnerabilities to achieve therapeutic effects.